Compare IONS & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IONS | WTRG |
|---|---|---|
| Founded | 1989 | 1901 |
| Country | United States | United States |
| Employees | N/A | 1615 |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 11.9B |
| IPO Year | 1996 | 1994 |
| Metric | IONS | WTRG |
|---|---|---|
| Price | $44.46 | $41.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 5 |
| Target Price | ★ $93.36 | $43.50 |
| AVG Volume (30 Days) | ★ 3.2M | 2.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.47% |
| EPS Growth | ★ 21.71 | 1.38 |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | ★ $2,474,615,000.00 |
| Revenue This Year | N/A | $5.07 |
| Revenue Next Year | $77.99 | $7.31 |
| P/E Ratio | ★ N/A | $35.88 |
| Revenue Growth | N/A | ★ 18.62 |
| 52 Week Low | $44.66 | $36.11 |
| 52 Week High | $86.74 | $42.51 |
| Indicator | IONS | WTRG |
|---|---|---|
| Relative Strength Index (RSI) | 26.02 | 50.31 |
| Support Level | N/A | $37.83 |
| Resistance Level | $78.11 | $41.55 |
| Average True Range (ATR) | 2.40 | 0.72 |
| MACD | -1.47 | -0.10 |
| Stochastic Oscillator | 3.39 | 27.00 |
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.